Researcher

Gang Liu

State Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory, Fujian Engineering Research Center of Molecular Theranostic Technology, School of Public Health, Xiamen University, Xiamen, 361102, China.

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · JOURNAL ARTICLE

Surgical decision–making in borderline resectable pancreatic cancer in the era of neoadjuvant therapy: from response assessment to individualized operative strategy

Frontiers in Surgery

This is a structured narrative review synthesizing evidence and international guidelines on surgical management of borderline resectable pancreatic cancer in the neoadjuvant therapy era, offering a practical decision-making framework rather than reporting original trial data.

Expert GuidanceCholangiocarcinoma and Gallbladder Cancer Studies Hongbin Han Mengxin Luo

Study details

DesignStructured narrative review of randomized a…

InterventionNeoadjuvant therapy followed by surgical re…

JUN 27, 2026 · JOURNAL ARTICLE

Immune cell-derived membrane nanovesicles: A promethean fire for autoimmune disease therapy through immune cell mimicry.

Bioactive Materials

This is a narrative review of an emerging nanotechnology platform with preclinical mechanistic concepts and no clinical trial data, raising therapeutic possibilities rather than testing them in humans.

Hypothesis-GeneratingAutoimmune Diseases Targeted Therapy Jimin Zhang

Reported

Global autoimmune disease prevale…approximately 5-10% of the global population

Sex distribution of autoimmune di…more prevalent in women than in men